Quantification of cerebral lateral ventricular volume in cats by low- and high-field MRI

Prevalence and clinical correlations of olfactory recess dilatation in MRI studies of the feline brain

The ability to differentiate clinical ventriculomegaly from incidental ventricular enlargement remains a challenge in veterinary radiology. Dilatation of one or both olfactory lobe recesses is occasionally seen on MRI of the brain in otherwise normal cats. The purpose of this study was therefore to determine the prevalence of this finding within a population of neurologically normal and neurologically abnormal cats, and to investigate associations with signalment, clinical and neurological examination findings, and MRI features. An observational retrospective cohort study was performed, and archived records were searched for cats that had undergone MRI of the head, including the olfactory lobes. Medical data and MRI parameters were recorded. One hundred fifty-one cats were included, with olfactory recess dilatation present in 56 cats. In 16 neurologically normal cats, olfactory recess dilatation was the only MRI finding. Olfactory recess dilatation was not associated with age, sex, breed, or with the presence of nasal disease. A significant association was found between generalized ventriculomegaly (P = 0.001) and the presence of CSF abnormalities (P = 0.036). Eleven percent of our cohort (16/151) demonstrated olfactory recess dilatation in the absence of other neurological or structural intracranial disease, suggesting that this may be seen as a normal variation in some cats.

A Historical Review of Brain Drug Delivery

The history of brain drug delivery is reviewed beginning with the first demonstration, in 1914, that a drug for syphilis, salvarsan, did not enter the brain, due to the presence of a blood-brain barrier (BBB). Owing to restricted transport across the BBB, FDA-approved drugs for the CNS have been generally limited to lipid-soluble small molecules. Drugs that do not cross the BBB can be re-engineered for transport on endogenous BBB carrier-mediated transport and receptor-mediated transport systems, which were identified during the 1970s-1980s. By the 1990s, a multitude of brain drug delivery technologies emerged, including trans-cranial delivery, CSF delivery, BBB disruption, lipid carriers, prodrugs, stem cells, exosomes, nanoparticles, gene therapy, and biologics. The advantages and limitations of each of these brain drug delivery technologies are critically reviewed.

D* from diffusion MRI reveals a correspondence between ventricular cerebrospinal fluid volume and flow in the ischemic rodent model

Quantitative measurement of cerebrospinal fluid (CSF) flow and volume and longitudinal monitoring of CSF dynamics provide insights into the compensatory characteristics of post-stroke CSF. In this study, we compared the MRI pseudo-diffusion index (D*) of live and sacrificed rat brains to confirm the effect of ventricular CSF flow on diffusion signals. We observed the relationship between the CSF peak velocities and D* through Monte Carlo (MC) simulations to further understand the source of D* contrast. We also determined the dominant CSF flow using D* in three directions. Finally, we investigated the dynamic evolutions of ventricular CSF flow and volume in a stroke rat model (n = 8) from preoperative to up to 45 days after surgery and determined the correlation between ventricular CSF volume and flow. MC simulations showed a strong positive correlation between the CSF peak velocity and D* (r = 0.99). The dominant CSF flow variations in the 3D ventricle could be measured using the maximum D* map. A longitudinal positive correlation between ventricular CSF volume and D* was observed in the lateral (r = 0.74) and ventral-third (r = 0.81) ventricles, respectively. The directional D* measurements provide quantitative CSF volume and flow information, which would provide useful insights into ischemic stroke with diffusion MRI.